Schrodinger, Inc. (NASDAQ:SDGR) Receives $24.33 Consensus Price Target from Analysts

Shares of Schrodinger, Inc. (NASDAQ:SDGR) have been assigned a consensus recommendation of “Hold” from the eleven analysts that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $24.3333.

Several research firms recently commented on SDGR. The Goldman Sachs Group began coverage on shares of Schrodinger in a research note on Monday, September 29th. They issued a “neutral” rating and a $19.00 price target on the stock. Wall Street Zen downgraded shares of Schrodinger from a “hold” rating to a “sell” rating in a research note on Saturday, January 10th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Schrodinger in a research note on Friday, January 9th. UBS Group assumed coverage on Schrodinger in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $18.00 price objective on the stock. Finally, Bank of America upgraded Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price objective on the stock in a report on Monday, December 15th.

Schrodinger Stock Performance

Shares of NASDAQ SDGR opened at $18.33 on Monday. Schrodinger has a fifty-two week low of $15.99 and a fifty-two week high of $28.47. The company has a market cap of $1.35 billion, a price-to-earnings ratio of -7.61 and a beta of 1.54. The business’s 50 day moving average price is $17.88 and its 200-day moving average price is $19.44.

Schrodinger (NASDAQ:SDGR) last announced its quarterly earnings data on Wednesday, November 5th. The company reported ($0.45) EPS for the quarter, beating the consensus estimate of ($0.72) by $0.27. Schrodinger had a negative return on equity of 48.24% and a negative net margin of 68.49%.The company had revenue of $54.32 million for the quarter, compared to the consensus estimate of $50.51 million. During the same quarter in the prior year, the company posted ($0.87) EPS. Schrodinger’s quarterly revenue was up 53.9% on a year-over-year basis. Sell-side analysts predict that Schrodinger will post -2.37 earnings per share for the current year.

Institutional Trading of Schrodinger

Several institutional investors and hedge funds have recently made changes to their positions in the company. Hennion & Walsh Asset Management Inc. grew its holdings in Schrodinger by 39.1% during the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 15,466 shares of the company’s stock worth $277,000 after acquiring an additional 4,350 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Schrodinger by 70.9% during the fourth quarter. SG Americas Securities LLC now owns 65,151 shares of the company’s stock valued at $1,165,000 after purchasing an additional 27,023 shares in the last quarter. Tudor Investment Corp ET AL increased its holdings in Schrodinger by 2,530.6% during the third quarter. Tudor Investment Corp ET AL now owns 336,379 shares of the company’s stock valued at $6,748,000 after buying an additional 323,592 shares during the period. CANADA LIFE ASSURANCE Co raised its stake in Schrodinger by 4.7% in the third quarter. CANADA LIFE ASSURANCE Co now owns 66,520 shares of the company’s stock worth $1,332,000 after buying an additional 2,995 shares in the last quarter. Finally, PharVision Advisers LLC purchased a new stake in Schrodinger during the third quarter worth $286,000. 79.05% of the stock is currently owned by institutional investors.

Schrodinger Company Profile

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.